Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The Effect of Previous Methylphenidate Use on Incidence of Stress Fractures in Military Recruits: A Retrospective Cohort.

Ben-Ami IS, Ankory R, Kadar A, Rotman D, Snir N, Schermann H.

J Bone Joint Surg Am. 2018 Jun 6;100(11):930-935. doi: 10.2106/JBJS.17.01267.

PMID:
29870443
2.

Past Methylphenidate Exposure and Stress Fractures in Combat Soldiers: A Case-Control Study.

Schermann H, Ben-Ami IS, Tudor A, Amar E, Rath E, Yanovich R.

Am J Sports Med. 2018 Mar;46(3):728-733. doi: 10.1177/0363546517741705. Epub 2017 Dec 13.

PMID:
29236514
3.

Lower risk of fractures under methylphenidate treatment for ADHD: A dose-response effect.

Schermann H, Gurel R, Ankory R, Kadar A, Yoffe V, Snir N, Sternheim A, Karakis I.

J Orthop Res. 2018 Dec;36(12):3328-3333. doi: 10.1002/jor.24129. Epub 2018 Sep 7.

PMID:
30129682
4.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

PMID:
26599576
5.

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2018 May 9;5:CD012069. doi: 10.1002/14651858.CD012069.pub2. Review.

6.

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Epstein T, Patsopoulos NA, Weiser M.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD005041.

PMID:
25230710
7.

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.

Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK; ADDUCE consortium.

CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7. Review.

8.

Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.

Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.

N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.

9.

Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.

Perry BA, Archer KR, Song Y, Ma Y, Green JK, Elefteriou F, Dahir KM.

Osteoporos Int. 2016 Jul;27(7):2223-2227. doi: 10.1007/s00198-016-3547-1. Epub 2016 Feb 29. Erratum in: Osteoporos Int. 2016 Jul;27(7):2229.

PMID:
26928186
10.

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC.

BMC Pediatr. 2012 Jun 19;12:78. doi: 10.1186/1471-2431-12-78.

11.

Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.

Olfson M, Marcus SC, Zhang HF, Wan GJ.

J Manag Care Pharm. 2007 Sep;13(7):570-7.

12.

Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.

Kang KD, Yun SW, Chung U, Kim TH, Park JH, Park IH, Han DH.

Hum Psychopharmacol. 2016 Mar;31(2):76-82. doi: 10.1002/hup.2514. Epub 2016 Jan 12.

PMID:
26756111
13.

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Osland ST, Steeves TD, Pringsheim T.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD007990. doi: 10.1002/14651858.CD007990.pub3. Review.

14.

Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.

Shyu YC, Yuan SS, Lee SY, Yang CJ, Yang KC, Lee TL, Wang LJ.

Schizophr Res. 2015 Oct;168(1-2):161-7. doi: 10.1016/j.schres.2015.08.033. Epub 2015 Sep 10.

PMID:
26363968
15.
16.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
17.

Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.

Liao YT, Yang YH, Kuo TY, Liang HY, Huang KY, Wang TN, Lee Y, McIntyre RS, Chen VC.

Eur Child Adolesc Psychiatry. 2018 Mar;27(3):279-288. doi: 10.1007/s00787-017-1042-7. Epub 2017 Aug 30.

PMID:
28856464
18.

Methylphenidate for children and adolescents with autism spectrum disorder.

Sturman N, Deckx L, van Driel ML.

Cochrane Database Syst Rev. 2017 Nov 21;11:CD011144. doi: 10.1002/14651858.CD011144.pub2. Review.

19.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

20.

Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.

Cox DJ, Davis M, Mikami AY, Singh H, Merkel RL, Burket R.

J Clin Psychopharmacol. 2012 Apr;32(2):225-30. doi: 10.1097/JCP.0b013e3182496dc5.

PMID:
22367664

Supplemental Content

Support Center